CLINICAL_TRIALS
trial_result
· 2022-04-12
Clinical Trial Update: Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema [Phase 3]
Summary
Phase 3 trial update on 9MW0813 for diabetic macular edema focusing on efficacy and safety.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. | Conditions: Diabetic Macular Edema | Phase 3 | Status: UNKNOWN